Advertisement

Topics

FDA gives rare pediatric disease status to MeiraGTx's achromatopsia drug

06:11 EDT 28 Aug 2018 | SmartBrief

MeiraGTx's AAV-CNGA3, being developed to treat patients with achromatopsia due to mutations in the CNGA3 gene, was given rare -More

Original Article: FDA gives rare pediatric disease status to MeiraGTx's achromatopsia drug

NEXT ARTICLE

More From BioPortfolio on "FDA gives rare pediatric disease status to MeiraGTx's achromatopsia drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...